Central diabetes insipidus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients below who consent to participate in this study in writing 1. Patients suspected as central diabetes insipidus 2. Patients already diagnosed as central diabetes insipidus 3. Patients with diencephalohypophysial diseases and no symptoms of diabetes insipidus
Exclusion criteria
Exclusion criteria: 1. Patients with heart and renal failure 2. Patients with bronchial asthma Pregnant or breastfeeding patients 3. Patients considered inappropriate for the participation in this study by doctors
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity of arginine stimulating test in diagnosis of central diabetes insipidus | — |
Secondary
| Measure | Time frame |
|---|---|
| Specificity of arginine stimulating test in diagnosis of central diabetes insipidus Incidence of adverse events Association between vasopressin concentrations measured by RIA or the LC-MS/MS method and serum sodium levels Comparison of diagnostic accuracy of central diabetes insipidus using vasopressin or copeptin measurements | — |
Contacts
Nagoya University Hospital